Shenzhen Hello Tech Energy (301327.SZ) plans to set up Xiamen Panorama Blueprint Venture Capital Fund with an investment of 30 million yuan, and will specifically invest in Zhengyang Technology.
Huabao New Energy (301327.SZ) announced that the company recently entered into a partnership with Shenzhen Panorama Blueprint Capital Limited (referred to as...
Shenzhen Hello Tech Energy (301327.SZ) announced that the company recently signed a limited partnership agreement with Shenzhen Panorama Blueprint Capital Limited (referred to as "Panorama Blueprint Capital") to jointly establish the Xiamen Panorama Blueprint Entrepreneurship Investment Fund Limited Partnership (referred to as "Xiamen Panorama Blueprint Venture Fund"). The company, as a limited partner, will contribute 30 million yuan from its own funds, with the commitment amount as the limit of liability. The fund partnership is a special fund that will specialize in investing in Guangdong Zhengyang Sensing Technology Co., Ltd. (referred to as "Zhengyang Technology") after registration.
The announcement reveals that Zhengyang Technology is a global automotive parts and assemblies supplier, with core products including SCR post-treatment related sensors, urea tank assemblies, VCU, PTC heaters, and other new energy products. With years of experience in the automotive industry, the company has qualifications as a Tier 1 supplier to over 100 global OEMs, and has subsidiaries or production bases in multiple countries. The company has established a supply chain cooperation foundation with Zhengyang Technology, starting from 2025, and has purchased communication harness and other raw materials, with a cumulative purchase amount of 1.3272 million yuan by the end of September.
This investment will help the company leverage Zhengyang Technology's customer channels, technological expertise, and overseas presence to enter the trillion-dollar new energy vehicle market, expand B-end application scenarios, achieve "C+B" dual-drive growth, and strengthen global supply chain coordination, laying the foundation for opening a second growth curve for the company.
Related Articles

VICON HOLDINGS (03878) announced its interim results, with a net profit attributable to shareholders of HK$5.566 million, a decrease of 13.3% year-on-year.

Zhejiang Medicine (600216.SH) plans to spin off its controlling subsidiary Newcode Biotech and list it on the Hong Kong Stock Exchange.

Tus-Pharmaceutical Group (000590.SZ) plans to change its name to "Guhan Pharmaceutical Group Co., Ltd."
VICON HOLDINGS (03878) announced its interim results, with a net profit attributable to shareholders of HK$5.566 million, a decrease of 13.3% year-on-year.

Zhejiang Medicine (600216.SH) plans to spin off its controlling subsidiary Newcode Biotech and list it on the Hong Kong Stock Exchange.

Tus-Pharmaceutical Group (000590.SZ) plans to change its name to "Guhan Pharmaceutical Group Co., Ltd."

RECOMMEND

Foreign Brands “Take On Chinese Names”: Starbucks And Burger King Change Hands As Chinese Capital’s Localization Scalpel Rewrites Global Rules
25/11/2025

Riding The Momentum Of Gemini 3, “Google Chain” Challenges “Nvidia Chain,” Reshaping The Ai Trading Landscape
25/11/2025

Silver Economy Accelerates As Personal Pension System Marks Three Years — Structural Changes Emerging
25/11/2025


